SSRL Science Highlight - May 2008 | |||||||||
Growth factors are peptides and proteins that function extracellularly to
regulate cell growth and differentiation. They play critical roles in
vertebrates as they coordinate the actions of cells within the same tissue, or
cells in one tissue or organ with those in another. They induce their
activities by binding and bringing together cell surface receptors, which
typically are comprised of an extracellular domain, a single membrane-spanning
domain, and an intracellular domain. The extracellular domains are responsible
for recognizing and binding the growth factor, while the intracellular domains,
when brought into close spatial proximity, are responsible for activating the
downstream machinery that brings about an appropriately tuned cellular
response.
Growth factors of the transforming growth factor-beta (TGF-b) superfamily have greatly diversified over the course of
evolution, with six such factors in nematodes, nine in fruit flies, and
forty-two in humans. They include the ancestral bone morphogenetic proteins
(BMPs), which play fundamental roles in embryonic patterning, the closely
related growth and differentiation factors (GDFs), which regulate cartilage and
skeletal development, the activins, which regulate the release of pituitary
hormones, and the evolutionary latecomers, the transforming growth factor-betas
(TGF-bs), which regulate cell growth and
morphogenesis. BMPs, GDFs, activins, and TGF-bs are
homodimers, consisting of two extended monomers held together in most, but not
all cases, by an inter-chain disulfide bond.
Figure 1:
Different modes of receptor complex assembly by TGF-bs and BMPs. (A) Representative dimeric ligand structures,
with the two monomers of TGF-b3 depicted in blue
and red, and those of BMP-2 in orange and brown. (B) Receptor extracellular
domains of the TGF-b superfamily adopt the same
three finger toxin fold, as shown by an overlay of the BMP and TGF b type I receptors on the left (cyan and yellow,
respectively), the BMP and TGF-b type II receptors
in the middle (magenta and green, respectively), and the TGF-b type I and type II receptors on the right (yellow and
green, respectively). F1, F2, and F3 designate the three fingers of the
receptor three-finger toxin fold. (C) TGF-b (left)
and BMP (right) type I receptor, type II receptor ternary complex structures.
TGF-b type I and type II receptors are shaded yellow
and green, respectively, and extensively contact one another. BMP type I and
type II receptors are shaded cyan and magenta respectively, and do not contact
one another.
TGF-bs and related factors induce their response by assembling a heterotetrameric
complex comprised of two type I - type II receptor pairs. Type I and type II
receptors have the same overall domain structure, including a cysteine rich
extracellular domain that adopts a three-finger toxin fold, a single
transmembrane helix, and an intracellular serine-threonine kinase domain. The
human genome encodes seven type I and five type II receptors. Through cell
based crosslinking studies, the BMPs and GDFs have been shown to bind multiple
type I and type II receptors in mixed order, while the TGF-bs bind a single type I and a single type II receptor in a
pronounced sequential order, first by binding the type II, TbR-II, followed by the type I,
TbR-I.
These biochemical findings provided the first hint that growth factor receptor
complexes of the family might differ structurally.
These differences have been borne out through direct structural analysis of BMP
and TGF b:type I receptor:type II receptor ternary
complexes. The structure of the BMP ternary complex was first inferred based
on independent structures of BMPs bound to BMP type I and type II receptors
(Kirsch, et al. and Greenwald, et al., respectively), and was later confirmed
by direct analysis of two closely related BMP ternary complexes (Allendorph, et
al. and Weber, et al.). The structure of the TGF-b ternary complex, recently
reported by Groppe, et al and the subject of this highlight, was determined by
direct structural analysis of the TGF b3:TbR I:TbR II ternary complex using a
crystal that diffracted to a resolution of 3.0 Å using SSRL beamline 11-1.
The structures of the ternary complexes reveal that although ligands and
receptors of the BMP and TGF-b subfamilies share the
same overall fold (Figures 1A and 1B, respectively), they nevertheless bind and
assemble their receptors into complexes in ways that are entirely distinct
(Figure 1C). The BMP type I and type II receptors bind to the ligand "wrist"
and "knuckle" epitopes, respectively, and do not contact one another, while the
TGF-b type I and type II receptors bind to the
underside of the "fingers" and to the "fingertips", respectively, and have
extensive contact. The additional constraints imposed by receptor-receptor
contact in the TGF-b, but not the BMP ternary
complex, is significant since its accounts for the highly specific and
pronounced stepwise manner of receptor binding exhibited by the
TGF-bs, but not
the BMPs. To demonstrate the functional significance of these, Groppe, et al. substituted a number of critical
contact residues in TbR-II, including F24 in the
TbR-II N-terminus and D118
near the tip of finger 3, and showed that these impair cooperative assembly
in vitro and TGF-b signaling
in vivo.
The BMP and TGF-b ternary complexes notably arise
from differences in both the manner of type I and type II receptor binding, and
hence represent four different modes of binding between molecules that
otherwise share the same overall folds (Figure 1A and 1B). This remarkable
diversity arises from simple evolutionary modifications of both the ligands and
receptors. Thus, as an example, BMPs include a short solvent-exposed helix
that binds into a pocket on the BMP type I receptor, BMPR-Ia. This short
helical segment in absent in the TGF-bs (Figure
2A), necessitating an alternate manner of type I receptor binding. This is
facilitated by a loop, extended in TbRI
relative to that in the BMP type I receptors, which binds deeply into a pocket
on the underside of the fingers of TGF-b (Figure
2B). This alternate positioning of TbR-I is further
supported by an extension of the N-terminal region of TbR-II, which packs against the surface of TbR-I and which fills a hydrophobic pocket on the surface
of TbR-I with conserved Phe (F22) and Val (V22)
residues (Figure 2C).
In summary, the results recently reported by Groppe, et al. provide a striking
example of how simple evolutionary modifications of ligands and receptors of
the TGF-b superfamily have enabled alternate modes
of receptor complex assembly. It seems likely, based on these observations,
that these alternate mechanisms of receptor assembly co-evolved with the
TGF-b and BMP specific classes of downstream
effectors (Smads) to expand and diversify the role of
TGF-b superfamily signaling in vertebrates.
Figure 2:
Structural features of the type I receptors and ligands that promote the switch
from the BMP to the TGF-b binding mode. (A)
Short extension, from D53 to L55, in BMP-2 (brown) packs into a complementary
pocket on the BMP type I receptor, BMPR-Ia (cyan). Such an extension is absent
in TGF-b3 (red), necessitating an alternate manner
of type I receptor binding.
(B) TbR-I, includes a loop extension (red) compared to the BMP type I
receptors, BMPR-Ia and BMPR-Ib. This extension contains two conserved prolines
(P55 and P59), as well as a conserved phenylalanine (F60), that bind into a
pocket on the underside of the TGF-b fingers formed
by W30, W32, Y90, and L101.
(C) The N-terminal region of TbR-II engages
TbR-I by packing against its
surface and by inserting two conserved hydrophobic residues, F24 and V22, into
a hydrophobic pocket on the surface of TbR-I.
TbR-II further engages TbR-I by
an ion pair formed between the carboxylate of TbR-II D118 and the guanidinium
group of TbR-I R58.
This work was funded by grants from the National Institutes of Health and the
Robert A. Welch Foundation (to A. Hinck) and grants from the Canadian
Institutes of Health Research and the National Cancer Institute of Canada (to
J. Wrana). This study also made use of the Macromolecular Structure Shared
Resource of San Antonio Cancer Institute, which is supported by the U. Texas
Health Science Center at San Antonio and the National Cancer Institute.
Primary Citation:
Additional References:
Jason Greenwald, Jay Groppe, Peter Gray, Ezra Wiater, Witek Kwiatkowski, Wylie
Vale, and Senyon Choe (2003) "The BMP7/ActRII extracellular domain complex
provides new insights into the cooperative nature of receptor assembly" Mol.
Cell, 11(3):605-617.
George P. Allendorph, Wylie W. Vale, Senyon Choe (2006). "Structure of the
ternary signaling complex of a TGF-beta superfamily member" Proc. Natl. Acad.
Sci. U.S.A. 103(20):7643-7648.
Dionys Weber, Alexander Kotzsch, Joachim Nickel, Stefan Harth, Axel Seher, Uwe
Mueller, Walter Sebald, and Thomas D. Mueller (2007) "A silent H-bond can be
mutationally activated for high-affinity interaction of BMP-2 and activin type
IIB receptor" BMC Struct. Biol. 7:6.
| |||||||||
SSRL is supported by the Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences. |
Last Updated: | 30 May 2008 |
Content Owner: | A. Hinck |
Page Editor: | L. Dunn |